News | Dravet Syndrome UK
Posted 22nd April 2022 in News
Further to recent news reports regarding concerns about the prescription of sodium valproate to women & girls of child-bearing age, please read our statement specifically clarifying use in Dravet Syndrome.
Posted 1st October 2021 in News
Tamara set up the #Run5KEveryDayinMay Challenge, inspired by her nephew, Dominic, who lives with Dravet Syndrome. We announced last week that Tamara had been shortlisted and now she has been announced as winner of the ITV Meridian Pride of Britain Award
Interim results from Stoke Therapeutics’ Phase 1/2a US study of STK-001 in children and adolescents (aged 2-18) with Dravet Syndrome.
Posted 21st September 2021 in News
We’re excited to share encouraging interim results from Stoke Therapeutics’ Phase 1/2a US study of STK-001 in children and adolescents (aged 2-18) with Dravet Syndrome
Posted 30th March 2021 in News
Stoke Therapeutics announce approval to start clinical trials in the UK for a developmental treatment for Dravet Syndrome, currently known as STK-001.
Topline results from second DSUK survey on the impact of COVID-19 provide reassurance for people affected by Dravet Syndrome
Posted 24th March 2021 in News
Overall, the results of the survey suggest that the SARS-CoV-2 vaccines are safe and well tolerated in people with DS, as they are in most people without DS.
Posted 22nd February 2021 in News
Epileptologist Professor Mike Kerr, neurologist Dr Julia Aram and Epilepsy Nurse Specialist Amanda Tomalin join the charity’s panel of Dravet Syndrome experts, chaired by Professor Helen Cross, OBE.
DSUK launches ambitious five-year strategy to guide it’s mission to bring hope to families living with Dravet Syndrome
Posted 15th February 2021 in News
Charity commits to reaching more families, delivering patient-centred research, improving awareness and understanding amongst professionals, and championing equity in care for children and adults.
Our take on key insights from today’s sessions at the BPNA.